Vitamin D [EPC]

Vitamin D [EPC] was reported 302520 times

Drugs of the Vitamin D [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5635 0.7857
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 503 0.7530
2 SWOLLEN JOINT COUNT INCREASED 2352 0.7368
3 PEMPHIGUS 9211 0.7360
4 RHEUMATIC FEVER 3170 0.7104
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1393 0.6955
6 DUODENAL ULCER PERFORATION 5136 0.6900
7 RHEUMATOID FACTOR POSITIVE 3774 0.6527
8 C-REACTIVE PROTEIN 592 0.6386
9 LUPUS VULGARIS 789 0.6262
10 FACET JOINT SYNDROME 1952 0.5990
11 HAND DEFORMITY 7776 0.5923
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1054 0.5082
13 HELICOBACTER INFECTION 5159 0.5015
14 DISLOCATION OF VERTEBRA 1061 0.4647
15 X-RAY ABNORMAL 794 0.4436
16 MUSCLE INJURY 3578 0.4314
17 SYNOVITIS 7763 0.4301
18 C-REACTIVE PROTEIN ABNORMAL 2707 0.4216
19 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2653 0.4081
20 RETINITIS 678 0.3921
21 GLOSSODYNIA 8757 0.3907
22 FOLLICULITIS 4077 0.3884
23 PERICARDITIS 6333 0.3766
24 PERIPHERAL VENOUS DISEASE 1482 0.3625
25 BLOOD PRESSURE SYSTOLIC ABNORMAL 848 0.3428
26 BLOOD PRESSURE DIASTOLIC ABNORMAL 856 0.3362
27 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 753 0.3265
28 SERONEGATIVE ARTHRITIS 371 0.3237
29 BONE EROSION 1046 0.2955
30 SYSTEMIC LUPUS ERYTHEMATOSUS 10336 0.2909
31 WOUND 7737 0.2765
32 CONTRAINDICATED PRODUCT ADMINISTERED 7425 0.2450
33 JOINT DESTRUCTION 369 0.2371
34 ENTHESOPATHY 366 0.2339
35 BREAST CANCER STAGE III 1511 0.2331
36 DRUG TOLERANCE DECREASED 643 0.2287
37 OPEN REDUCTION OF FRACTURE 258 0.2251
38 INTRAMEDULLARY ROD INSERTION 456 0.2223
39 GRIP STRENGTH DECREASED 1933 0.2194
40 HYPERCHOLESTEROLAEMIA 2111 0.2184
41 JOINT RANGE OF MOTION DECREASED 2930 0.2182
42 BURSITIS 2640 0.2174
43 LIP DRY 1929 0.2122
44 PORPHYRIA ACUTE 296 0.2063
45 ONYCHOMADESIS 866 0.2061
46 LIVE BIRTH 1672 0.1997
47 IRRITABLE BOWEL SYNDROME 4237 0.1974
48 RHEUMATOID NODULE 544 0.1973
49 WOUND INFECTION 2125 0.1939
50 ONYCHOMYCOSIS 809 0.1842
51 ANAEMIA POSTOPERATIVE 237 0.1815
52 ARTHROPATHY 9947 0.1788
53 FIBROMYALGIA 4256 0.1749
54 BLOOD PARATHYROID HORMONE DECREASED 248 0.1672
55 TENOSYNOVITIS 458 0.1659
56 IMPAIRED HEALING 5414 0.1647
57 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1819 0.1642
58 LOW TURNOVER OSTEOPATHY 656 0.1640
59 RHEUMATOID ARTHRITIS 18381 0.1617
60 FINGER DEFORMITY 765 0.1578
61 AUTOIMMUNE DISORDER 1520 0.1558
62 BLEPHAROSPASM 939 0.1490
63 PSORIATIC ARTHROPATHY 5936 0.1461
64 EXOSTOSIS 1328 0.1453
65 FOOT DEFORMITY 1580 0.1424
66 INFUSION RELATED REACTION 9119 0.1374
67 SCIATICA 2162 0.1355
68 LIVER INJURY 3295 0.1341
69 HIP ARTHROPLASTY 2046 0.1335
70 OSTEOARTHRITIS 5648 0.1331
71 OBESITY 2030 0.1273
72 TYPE 2 DIABETES MELLITUS 4209 0.1249
73 MATERNAL EXPOSURE TIMING UNSPECIFIED 467 0.1242
74 NAIL DISORDER 1074 0.1226
75 DYSMORPHISM 288 0.1221
76 JOINT EFFUSION 836 0.1211
77 THERAPEUTIC PRODUCT EFFECT DECREASED 5370 0.1198
78 PULMONARY FIBROSIS 2291 0.1193
79 LOWER RESPIRATORY TRACT INFECTION 5411 0.1189
80 BLOOD PRESSURE DIASTOLIC DECREASED 878 0.1188
81 HEPATIC ENZYME INCREASED 7606 0.1115
82 KNEE ARTHROPLASTY 2345 0.1113
83 DISCOMFORT 6742 0.1104
84 INFUSION SITE REACTION 328 0.1097
85 PANNICULITIS 264 0.1090
86 ALANINE AMINOTRANSFERASE ABNORMAL 227 0.1075
87 WALKING AID USER 708 0.1073
88 JOINT DISLOCATION 1134 0.1072
89 POLYARTHRITIS 564 0.1069
90 SWELLING 9903 0.1057
91 BLOOD PRESSURE DIASTOLIC INCREASED 479 0.1037
92 C-REACTIVE PROTEIN INCREASED 3763 0.1033
93 JOINT SWELLING 12413 0.1027
94 LUPUS-LIKE SYNDROME 926 0.1020
95 BLOOD PRESSURE SYSTOLIC INCREASED 1978 0.1013
96 BLOOD CHOLESTEROL INCREASED 4676 0.1002
97 MATERNAL EXPOSURE DURING PREGNANCY 8825 0.0989
98 SYNOVIAL CYST 455 0.0984
99 SPINAL OSTEOARTHRITIS 863 0.0981
100 BLISTER 5453 0.0970
101 SPONDYLITIS 350 0.0962
102 PUSTULAR PSORIASIS 328 0.0954
103 AORTIC ARTERIOSCLEROSIS 237 0.0920
104 LOWER LIMB FRACTURE 1750 0.0910
105 INTERVERTEBRAL DISC DEGENERATION 839 0.0906
106 STOMATITIS 5478 0.0902
107 DRUG INTOLERANCE 8594 0.0889
108 PLEURITIC PAIN 244 0.0883
109 MUSCULOSKELETAL STIFFNESS 7721 0.0880
110 STRESS FRACTURE 473 0.0876
111 SICKLE CELL ANAEMIA WITH CRISIS 1381 0.0875
112 PRESCRIBED OVERDOSE 1651 0.0852
113 BACK INJURY 916 0.0841
114 INFLAMMATION 4327 0.0838
115 NEPHROGENIC ANAEMIA 387 0.0835
116 GESTATIONAL DIABETES 396 0.0830
117 BLOOD PRESSURE FLUCTUATION 1977 0.0823
118 GAIT INABILITY 2738 0.0818
119 SMALL FOR DATES BABY 406 0.0817
120 JOINT STIFFNESS 2094 0.0797
121 BODY TEMPERATURE DECREASED 780 0.0792
122 LUMBAR SPINAL STENOSIS 229 0.0783
123 CONGENITAL ANOMALY 605 0.0781
124 FEMUR FRACTURE 2394 0.0772
125 DRUG TOLERANCE 389 0.0768
126 ABDOMINAL DISCOMFORT 12833 0.0764
127 MOBILITY DECREASED 5413 0.0753
128 MUSCULOSKELETAL PAIN 3945 0.0752
129 ARTHRITIS INFECTIVE 349 0.0752
130 NIGHT SWEATS 2424 0.0752
131 ULCER HAEMORRHAGE 509 0.0751
132 SINUSITIS 7602 0.0741
133 CUSHINGOID 237 0.0738
134 RED CELL DISTRIBUTION WIDTH INCREASED 303 0.0729
135 VITAMIN D DEFICIENCY 711 0.0728
136 ANTINUCLEAR ANTIBODY POSITIVE 235 0.0723
137 SPINAL FUSION SURGERY 289 0.0712
138 TREATMENT FAILURE 5882 0.0709
139 SPINAL STENOSIS 293 0.0709
140 NORMAL NEWBORN 382 0.0702
141 PREGNANCY 1403 0.0700
142 COELIAC DISEASE 686 0.0699
143 SCOLIOSIS 428 0.0690
144 SPINAL COLUMN STENOSIS 326 0.0690
145 HAEMORRHAGIC ANAEMIA 303 0.0689
146 PRESCRIBED UNDERDOSE 1375 0.0689
147 PRODUCT LABEL CONFUSION 401 0.0687
148 HEPATIC CIRRHOSIS 1288 0.0685
149 OSTEOPOROSIS 2801 0.0680
150 NODULE 884 0.0677
151 SERUM FERRITIN INCREASED 357 0.0676
152 WHEEZING 4006 0.0675
153 BASAL CELL CARCINOMA 1043 0.0668
154 EXPOSURE DURING PREGNANCY 4150 0.0667
155 TENDERNESS 693 0.0664
156 BRONCHIECTASIS 446 0.0661
157 LIVER FUNCTION TEST INCREASED 1410 0.0656
158 MENISCUS INJURY 402 0.0653
159 ALOPECIA 12828 0.0653
160 OEDEMA 3540 0.0652
161 CONTUSION 6244 0.0648
162 CARDIAC MURMUR 557 0.0643
163 ARTHRITIS 5047 0.0641
164 ILL-DEFINED DISORDER 3882 0.0638
165 CHRONIC SINUSITIS 239 0.0636
166 NEONATAL RESPIRATORY DISTRESS SYNDROME 224 0.0632
167 EAR INFECTION 1681 0.0631
168 INTENTIONAL PRODUCT USE ISSUE 5528 0.0630
169 IMMUNODEFICIENCY 937 0.0628
170 VENTRICULAR SEPTAL DEFECT 356 0.0621
171 RASH VESICULAR 300 0.0620
172 INFLAMMATORY MARKER INCREASED 304 0.0613
173 TIBIA FRACTURE 286 0.0609
174 BREAST CANCER STAGE II 506 0.0608
175 ATRIAL SEPTAL DEFECT 508 0.0606
176 POSTOPERATIVE WOUND INFECTION 409 0.0605
177 ARTHRITIS BACTERIAL 248 0.0604
178 ROTATOR CUFF SYNDROME 770 0.0599
179 DIVERTICULUM 426 0.0599
180 OSTEOPENIA 909 0.0598
181 PRE-ECLAMPSIA 284 0.0597
182 GENERAL PHYSICAL HEALTH DETERIORATION 6898 0.0596
183 WHEELCHAIR USER 265 0.0596
184 VITAMIN B12 DEFICIENCY 241 0.0595
185 PERIPHERAL SWELLING 9144 0.0593
186 LUNG DISORDER 2907 0.0593
187 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2847 0.0592
188 PREMATURE LABOUR 335 0.0592
189 BREATH SOUNDS ABNORMAL 292 0.0592
190 IRON DEFICIENCY 266 0.0591
191 ANAL FISSURE 316 0.0589
192 HAEMATOCRIT DECREASED 1166 0.0587
193 INJECTION SITE PAPULE 267 0.0583
194 MATERNAL EXPOSURE BEFORE PREGNANCY 394 0.0576
195 EAR PAIN 1114 0.0572
196 LOW BIRTH WEIGHT BABY 452 0.0568
197 POOR VENOUS ACCESS 588 0.0568
198 ROAD TRAFFIC ACCIDENT 2372 0.0566
199 NASOPHARYNGITIS 10446 0.0566
200 INJURY 3967 0.0564
201 VITAMIN D DECREASED 481 0.0562
202 ATELECTASIS 542 0.0560
203 SKIN NECROSIS 290 0.0558
204 SKIN PAPILLOMA 224 0.0558
205 CARPAL TUNNEL SYNDROME 782 0.0558
206 HAEMOLYSIS 427 0.0552
207 GOITRE 226 0.0551
208 HUMERUS FRACTURE 266 0.0551
209 DIVERTICULUM INTESTINAL 241 0.0551
210 HIATUS HERNIA 712 0.0549
211 HYPERLIPIDAEMIA 652 0.0545
212 SLEEP DISORDER 3842 0.0544
213 RENAL CYST 432 0.0543
214 FOOT OPERATION 269 0.0543
215 SKIN ABRASION 256 0.0541
216 GASTROINTESTINAL DISORDER 4841 0.0540
217 ARTHRALGIA 22259 0.0535
218 HEART RATE DECREASED 1879 0.0535
219 RHINITIS 429 0.0532
220 TASTE DISORDER 1075 0.0529
221 FOOT FRACTURE 995 0.0524
222 INFECTION 7585 0.0524
223 UPPER RESPIRATORY TRACT INFECTION 2393 0.0517
224 UMBILICAL HERNIA 242 0.0517
225 TENDONITIS 801 0.0517
226 LIGAMENT RUPTURE 228 0.0516
227 BONE DISORDER 939 0.0515
228 TOOTH ABSCESS 521 0.0511
229 TONGUE DISORDER 368 0.0508
230 TOOTH INFECTION 669 0.0507
231 LOCALISED INFECTION 1219 0.0504
232 FOETAL GROWTH RESTRICTION 304 0.0500
233 JOINT INJURY 1068 0.0499
234 POST PROCEDURAL INFECTION 406 0.0499
235 TOOTH FRACTURE 547 0.0496
236 LIGAMENT SPRAIN 490 0.0495
237 HAND FRACTURE 351 0.0495
238 MOUTH ULCERATION 1043 0.0495
239 LIVER DISORDER 2194 0.0494
240 APHTHOUS ULCER 383 0.0493
241 THERAPY NON-RESPONDER 2218 0.0493
242 SPINAL COMPRESSION FRACTURE 406 0.0491
243 BRONCHITIS 3618 0.0488
244 HYPERSENSITIVITY 9050 0.0487
245 SKIN ULCER 1255 0.0485
246 CAESAREAN SECTION 565 0.0485
247 NECK PAIN 2711 0.0485
248 SQUAMOUS CELL CARCINOMA OF SKIN 292 0.0483
249 ANAL FISTULA 257 0.0481
250 EPILEPSY 1470 0.0480
251 PELVIC FRACTURE 373 0.0479
252 DRY MOUTH 3886 0.0478
253 HYPERKERATOSIS 264 0.0478
254 INCREASED TENDENCY TO BRUISE 440 0.0478
255 ULCER 760 0.0477
256 MATERNAL DRUGS AFFECTING FOETUS 364 0.0474
257 RESPIRATORY RATE INCREASED 421 0.0474
258 HAEMOGLOBIN DECREASED 4862 0.0473
259 NERVE COMPRESSION 436 0.0472
260 STILLBIRTH 228 0.0471
261 PHARYNGITIS 585 0.0471
262 BLOOD ALBUMIN DECREASED 374 0.0471
263 GASTROOESOPHAGEAL REFLUX DISEASE 3795 0.0471
264 CYST 585 0.0471
265 GINGIVAL PAIN 373 0.0468
266 HYPERCALCAEMIA 578 0.0468
267 BLOOD IRON DECREASED 555 0.0467
268 MUSCLE STRAIN 404 0.0467
269 SPINAL DISORDER 442 0.0466
270 PULMONARY MASS 693 0.0465
271 CELLULITIS 2334 0.0463
272 FREQUENT BOWEL MOVEMENTS 1248 0.0462
273 IRON DEFICIENCY ANAEMIA 425 0.0460
274 SINUS CONGESTION 622 0.0460
275 SENSITIVITY TO WEATHER CHANGE 242 0.0459
276 PANCYTOPENIA 2568 0.0459
277 RESPIRATORY TRACT INFECTION 1191 0.0457
278 DENTAL CARIES 501 0.0452
279 OXYGEN SATURATION DECREASED 2538 0.0451
280 SKIN LACERATION 491 0.0451
281 DELIRIUM 1560 0.0449
282 INTERVERTEBRAL DISC PROTRUSION 982 0.0449
283 BENIGN PROSTATIC HYPERPLASIA 231 0.0447
284 TOOTH DISORDER 992 0.0446
285 FOETAL EXPOSURE DURING PREGNANCY 3620 0.0445
286 HYPOAESTHESIA 6662 0.0445
287 IMMUNOSUPPRESSION 392 0.0444
288 INGUINAL HERNIA 270 0.0443
289 CONFUSIONAL STATE 7166 0.0443
290 GASTROENTERITIS VIRAL 800 0.0443
291 MYOSITIS 397 0.0442
292 DYSLIPIDAEMIA 224 0.0441
293 HEPATITIS 1128 0.0440
294 HYPERTENSION 9320 0.0440
295 TRICUSPID VALVE INCOMPETENCE 348 0.0438
296 WRIST FRACTURE 520 0.0433
297 DISABILITY 857 0.0433
298 APLASTIC ANAEMIA 226 0.0432
299 BLOOD MAGNESIUM DECREASED 373 0.0432
300 RED BLOOD CELL COUNT DECREASED 1235 0.0432
301 WEIGHT INCREASED 9643 0.0430
302 ARTHROPOD BITE 319 0.0430
303 SKIN INFECTION 482 0.0429
304 RIB FRACTURE 881 0.0428
305 LACERATION 402 0.0427
306 PAIN IN EXTREMITY 12574 0.0426
307 PAIN 26066 0.0424
308 HEPATIC STEATOSIS 787 0.0422
309 PLATELET COUNT INCREASED 549 0.0421
310 OEDEMA PERIPHERAL 5127 0.0420
311 CATARACT OPERATION 249 0.0419
312 POLYP 274 0.0418
313 DRUG-INDUCED LIVER INJURY 1312 0.0418
314 DYSPEPSIA 4106 0.0417
315 GASTROENTERITIS 609 0.0417
316 BODY HEIGHT DECREASED 445 0.0416
317 MASS 581 0.0415
318 ANKYLOSING SPONDYLITIS 547 0.0415
319 GINGIVITIS 223 0.0413
320 OSTEOMYELITIS 748 0.0413
321 COMPRESSION FRACTURE 221 0.0412
322 GROIN PAIN 362 0.0412
323 HERPES ZOSTER 2365 0.0411
324 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 705 0.0411
325 ADRENAL INSUFFICIENCY 499 0.0411
326 CONDITION AGGRAVATED 12466 0.0410
327 BACK DISORDER 662 0.0407
328 LARGE INTESTINE POLYP 282 0.0407
329 BREAST MASS 273 0.0406
330 TENDON DISORDER 265 0.0406
331 LOCAL SWELLING 708 0.0405
332 DIVERTICULITIS 1116 0.0402
333 ARTERIOSCLEROSIS CORONARY ARTERY 266 0.0401
334 CYSTITIS 1277 0.0401
335 HAEMORRHOIDS 776 0.0397
336 SPLENOMEGALY 466 0.0397
337 FISTULA 447 0.0397
338 PRODUCT USE ISSUE 7470 0.0397
339 SQUAMOUS CELL CARCINOMA 374 0.0397
340 MITRAL VALVE INCOMPETENCE 449 0.0396
341 MIGRAINE 3767 0.0394
342 FLANK PAIN 369 0.0393
343 OVARIAN CYST 393 0.0393
344 RECTAL HAEMORRHAGE 1689 0.0393
345 WEIGHT FLUCTUATION 409 0.0391
346 NEUTROPENIC SEPSIS 279 0.0390
347 HYSTERECTOMY 338 0.0390
348 SLEEP APNOEA SYNDROME 744 0.0389
349 PRE-EXISTING CONDITION IMPROVED 243 0.0389
350 PLEURISY 231 0.0389
351 PNEUMONIA 12586 0.0388
352 MUSCULOSKELETAL CHEST PAIN 598 0.0386
353 ORAL CANDIDIASIS 508 0.0385
354 PREMATURE DELIVERY 614 0.0385
355 SMALL INTESTINAL OBSTRUCTION 473 0.0384
356 ANKLE FRACTURE 593 0.0383
357 UTERINE LEIOMYOMA 279 0.0381
358 WHITE BLOOD CELL COUNT INCREASED 1464 0.0381
359 MALIGNANT MELANOMA 511 0.0381
360 MUSCULOSKELETAL DISCOMFORT 656 0.0381
361 TRANSFUSION 399 0.0380
362 EMPHYSEMA 384 0.0380
363 KIDNEY INFECTION 741 0.0377
364 LIMB INJURY 1024 0.0377
365 OROPHARYNGEAL PAIN 3487 0.0376
366 SPINAL PAIN 441 0.0376
367 CARDIOMEGALY 462 0.0375
368 VASCULITIS 437 0.0375
369 MUSCULAR WEAKNESS 4242 0.0373
370 TOOTHACHE 675 0.0372
371 UVEITIS 501 0.0369
372 ORAL HERPES 719 0.0368
373 GASTRITIS 968 0.0367
374 URINARY TRACT INFECTION 6273 0.0367
375 GAIT DISTURBANCE 7028 0.0367
376 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2611 0.0367
377 RESPIRATORY TRACT CONGESTION 583 0.0367
378 SEASONAL ALLERGY 519 0.0366
379 HEART RATE IRREGULAR 821 0.0363
380 ECCHYMOSIS 249 0.0363
381 PAROSMIA 274 0.0363
382 GASTROINTESTINAL INFECTION 325 0.0362
383 ABORTION SPONTANEOUS 1450 0.0362
384 RENAL FAILURE CHRONIC 278 0.0361
385 TENDON RUPTURE 446 0.0361
386 RASH 15735 0.0361
387 HAEMOGLOBIN ABNORMAL 232 0.0360
388 FATIGUE 28037 0.0360
389 ABSCESS 574 0.0359
390 END STAGE RENAL DISEASE 656 0.0359
391 DRUG EXPOSURE DURING PREGNANCY 1222 0.0359
392 CATARACT 2135 0.0358
393 PHARYNGITIS STREPTOCOCCAL 387 0.0357
394 PREMATURE BABY 1076 0.0357
395 PRODUCTIVE COUGH 1693 0.0354
396 PYREXIA 12269 0.0354
397 CHEST PAIN 6545 0.0353
398 UROSEPSIS 325 0.0352
399 CHOLELITHIASIS 1152 0.0351
400 SPUTUM DISCOLOURED 333 0.0351
401 UPPER-AIRWAY COUGH SYNDROME 289 0.0350
402 VIRAL INFECTION 1165 0.0350
403 FALL 11624 0.0349
404 ANAEMIA 6652 0.0348
405 INJECTION SITE HAEMATOMA 506 0.0348
406 ORAL DISORDER 255 0.0348
407 CROHN'S DISEASE 238 0.0347
408 DYSPNOEA EXERTIONAL 1304 0.0346
409 DECUBITUS ULCER 281 0.0344
410 LUNG INFILTRATION 304 0.0344
411 BLOOD URINE PRESENT 653 0.0344
412 WEIGHT DECREASED 9562 0.0342
413 FURUNCLE 271 0.0342
414 BODY TEMPERATURE INCREASED 696 0.0341
415 RHINORRHOEA 2203 0.0340
416 UPPER LIMB FRACTURE 679 0.0340
417 BLOOD PRESSURE INCREASED 5198 0.0340
418 GASTRIC ULCER 646 0.0340
419 NEPHROLITHIASIS 1558 0.0339
420 ESCHERICHIA INFECTION 279 0.0339
421 FAECES SOFT 246 0.0338
422 CORONARY ARTERY OCCLUSION 461 0.0336
423 GOUT 602 0.0335
424 HYDRONEPHROSIS 251 0.0335
425 GASTROINTESTINAL INFLAMMATION 262 0.0334
426 BLOOD POTASSIUM DECREASED 1005 0.0334
427 OESOPHAGITIS 364 0.0333
428 MUSCULOSKELETAL DISORDER 634 0.0333
429 NASAL CONGESTION 1955 0.0332
430 PYELONEPHRITIS 288 0.0332
431 ABDOMINAL PAIN UPPER 6793 0.0330
432 AMNESIA 2146 0.0330
433 LIVER FUNCTION TEST ABNORMAL 957 0.0329
434 HYPERAESTHESIA 270 0.0328
435 EYE INFECTION 370 0.0327
436 TOOTH EXTRACTION 407 0.0327
437 RASH PRURITIC 1767 0.0326
438 BLOOD TEST ABNORMAL 458 0.0326
439 MALNUTRITION 364 0.0325
440 HAEMATOCHEZIA 1793 0.0325
441 LOWER GASTROINTESTINAL HAEMORRHAGE 240 0.0324
442 PSORIASIS 4236 0.0324
443 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1690 0.0324
444 INFLUENZA 3608 0.0323
445 ASTHMA 3653 0.0323
446 BACK PAIN 7508 0.0323
447 ABDOMINAL PAIN 7511 0.0323
448 ORAL PAIN 722 0.0322
449 AORTIC ANEURYSM 245 0.0322
450 BLOOD CALCIUM INCREASED 282 0.0321
451 ADVERSE REACTION 426 0.0321
452 ARTERIOSCLEROSIS 301 0.0319
453 RESPIRATORY DISORDER 953 0.0318
454 HEPATOMEGALY 313 0.0318
455 CLOSTRIDIUM DIFFICILE INFECTION 693 0.0317
456 MUCOSAL INFLAMMATION 831 0.0317
457 DECREASED APPETITE 7370 0.0317
458 HYPOKALAEMIA 1460 0.0316
459 INJECTION SITE WARMTH 649 0.0315
460 FEAR OF INJECTION 225 0.0315
461 STAPHYLOCOCCAL INFECTION 1040 0.0315
462 CHOLECYSTECTOMY 360 0.0315
463 PARAESTHESIA 4956 0.0315
464 HERNIA 609 0.0315
465 PLEURAL EFFUSION 1916 0.0315
466 INJECTION SITE PRURITUS 2101 0.0313
467 URINE OUTPUT DECREASED 274 0.0313
468 INJECTION SITE EXTRAVASATION 386 0.0313
469 INJECTION SITE REACTION 2149 0.0312
470 FULL BLOOD COUNT ABNORMAL 329 0.0311
471 BLOOD CALCIUM DECREASED 348 0.0309
472 APHONIA 429 0.0307
473 COLITIS ULCERATIVE 1372 0.0307
474 CONCUSSION 237 0.0306
475 SKIN LESION 839 0.0306
476 SUPRAVENTRICULAR TACHYCARDIA 292 0.0305
477 GALLBLADDER DISORDER 544 0.0304
478 ATRIAL FLUTTER 243 0.0304
479 BACTERIAL INFECTION 568 0.0304
480 PHOTOPHOBIA 572 0.0304
481 DYSSTASIA 887 0.0303
482 COUGH 8512 0.0303
483 IMMUNE SYSTEM DISORDER 399 0.0302
484 GLAUCOMA 583 0.0302
485 BLOOD UREA INCREASED 506 0.0302
486 SEPTIC SHOCK 1314 0.0302
487 NEURALGIA 734 0.0302
488 URTICARIA 5051 0.0301
489 ASTHENIA 11316 0.0301
490 HYPOTHYROIDISM 961 0.0301
491 BLOOD LACTATE DEHYDROGENASE INCREASED 476 0.0300
492 SINUS DISORDER 594 0.0300
493 LYMPHADENOPATHY 1057 0.0298
494 CLOSTRIDIUM DIFFICILE COLITIS 316 0.0298
495 CHROMATURIA 671 0.0297
496 INJECTION SITE IRRITATION 378 0.0297
497 LIMB DISCOMFORT 919 0.0297
498 MEDICATION ERROR 1649 0.0296
499 PETECHIAE 308 0.0295
500 BLOOD SODIUM DECREASED 556 0.0295
501 ELECTROCARDIOGRAM ABNORMAL 231 0.0294
502 FRACTURE 556 0.0293
503 PULMONARY HYPERTENSION 611 0.0293
504 NOCTURIA 356 0.0293
505 DEFORMITY 274 0.0293
506 DEPRESSION 6664 0.0293
507 MEMORY IMPAIRMENT 4022 0.0292
508 HAEMOLYTIC ANAEMIA 262 0.0292
509 EAR DISCOMFORT 300 0.0292
510 SECRETION DISCHARGE 366 0.0292
511 ACUTE RESPIRATORY FAILURE 562 0.0292
512 IMPAIRED WORK ABILITY 623 0.0291
513 FUNGAL INFECTION 966 0.0290
514 POST PROCEDURAL COMPLICATION 556 0.0289
515 MUSCLE SPASMS 5307 0.0289
516 UPPER GASTROINTESTINAL HAEMORRHAGE 486 0.0289
517 DRUG LEVEL DECREASED 293 0.0288
518 HEPATIC CYTOLYSIS 367 0.0288
519 HIP FRACTURE 925 0.0287
520 SCAB 328 0.0287
521 NEUTROPHIL COUNT INCREASED 293 0.0286
522 SKIN CANCER 616 0.0286
523 TRANSIENT ISCHAEMIC ATTACK 964 0.0285
524 CONJUNCTIVITIS 529 0.0285
525 LUNG INFECTION 442 0.0284
526 MICTURITION URGENCY 324 0.0283
527 LABORATORY TEST ABNORMAL 837 0.0283
528 DYSPNOEA 16053 0.0283
529 OBSTRUCTIVE AIRWAYS DISORDER 315 0.0283
530 ALANINE AMINOTRANSFERASE INCREASED 1736 0.0282
531 DRUG ERUPTION 501 0.0282
532 TUBULOINTERSTITIAL NEPHRITIS 529 0.0282
533 BLOOD DISORDER 226 0.0282
534 ABDOMINAL DISTENSION 2943 0.0282
535 KNEE OPERATION 277 0.0281
536 MACULAR DEGENERATION 336 0.0281
537 CANDIDA INFECTION 473 0.0280
538 HEADACHE 17529 0.0279
539 SEPSIS 3113 0.0279
540 FULL BLOOD COUNT DECREASED 560 0.0278
541 ATRIAL FIBRILLATION 2705 0.0277
542 RESTLESS LEGS SYNDROME 503 0.0276
543 MYELODYSPLASTIC SYNDROME 400 0.0276
544 BLOOD COUNT ABNORMAL 419 0.0276
545 INSOMNIA 7355 0.0276
546 VOMITING 12983 0.0276
547 COLITIS 1046 0.0276
548 FEELING HOT 1690 0.0275
549 INCONTINENCE 290 0.0274
550 DIARRHOEA 17708 0.0274
551 DIZZINESS POSTURAL 266 0.0274
552 DIARRHOEA HAEMORRHAGIC 256 0.0274
553 INJECTION SITE NODULE 301 0.0273
554 MUSCLE SPASTICITY 336 0.0273
555 SPINAL FRACTURE 547 0.0273
556 PNEUMONITIS 743 0.0273
557 DEHYDRATION 3636 0.0272
558 GINGIVAL BLEEDING 372 0.0272
559 HYPOMAGNESAEMIA 379 0.0272
560 NEPHROPATHY 254 0.0272
561 FLUID RETENTION 1383 0.0272
562 THROAT IRRITATION 1219 0.0271
563 PNEUMONIA ASPIRATION 678 0.0271
564 ANAL INCONTINENCE 244 0.0271
565 IMPAIRED QUALITY OF LIFE 389 0.0270
566 DRY THROAT 275 0.0270
567 CORONARY ARTERY DISEASE 819 0.0270
568 HYPOCALCAEMIA 511 0.0270
569 DYSURIA 993 0.0270
570 PNEUMOCYSTIS JIROVECII PNEUMONIA 270 0.0269
571 PAIN IN JAW 760 0.0268
572 THERAPEUTIC RESPONSE DECREASED 1622 0.0267
573 PERICARDIAL EFFUSION 617 0.0267
574 ADVERSE DRUG REACTION 2395 0.0266
575 ADVERSE EVENT 2457 0.0266
576 INTERNATIONAL NORMALISED RATIO INCREASED 760 0.0266
577 NERVE INJURY 296 0.0266
578 INJECTION SITE BRUISING 2122 0.0266
579 PULMONARY CONGESTION 350 0.0265
580 THYROID DISORDER 409 0.0265
581 BLOOD CREATININE INCREASED 1731 0.0265
582 INJECTION SITE DISCOLOURATION 331 0.0265
583 BLADDER DISORDER 263 0.0265
584 ELECTROLYTE IMBALANCE 306 0.0263
585 MALAISE 11551 0.0263
586 INJECTION SITE ERYTHEMA 3264 0.0263
587 ASPARTATE AMINOTRANSFERASE INCREASED 1397 0.0263
588 URINARY INCONTINENCE 779 0.0263
589 HYPOPHAGIA 672 0.0263
590 PLATELET COUNT DECREASED 2777 0.0260
591 DEEP VEIN THROMBOSIS 1690 0.0260
592 COVID-19 PNEUMONIA 307 0.0260
593 DERMATITIS ALLERGIC 326 0.0259
594 INITIAL INSOMNIA 265 0.0258
595 HYPOKINESIA 374 0.0257
596 DIZZINESS 12837 0.0257
597 CHRONIC KIDNEY DISEASE 1951 0.0257
598 EPISTAXIS 1918 0.0256
599 LEUKOCYTOSIS 464 0.0256
600 PERIPHERAL COLDNESS 352 0.0256
601 CHOLECYSTITIS 305 0.0256
602 DECREASED IMMUNE RESPONSIVENESS 251 0.0256
603 RASH PAPULAR 571 0.0255
604 SKIN DISCOLOURATION 1169 0.0254
605 BLOOD POTASSIUM INCREASED 413 0.0254
606 THROMBOCYTOPENIA 2834 0.0253
607 HEART RATE INCREASED 2508 0.0253
608 INFUSION SITE PAIN 326 0.0253
609 MOVEMENT DISORDER 811 0.0252
610 PALLOR 687 0.0252
611 BALANCE DISORDER 2180 0.0252
612 PRURITUS 9689 0.0252
613 ASPIRATION 276 0.0252
614 FEELING COLD 701 0.0252
615 SPINAL OPERATION 310 0.0251
616 RENAL TUBULAR NECROSIS 246 0.0251
617 ACUTE KIDNEY INJURY 3837 0.0250
618 CHILLS 2936 0.0250
619 RENAL FAILURE ACUTE 1062 0.0250
620 POLLAKIURIA 1042 0.0250
621 POOR QUALITY SLEEP 536 0.0249
622 LYMPHOCYTE COUNT DECREASED 440 0.0249
623 NAUSEA 19661 0.0248
624 INTESTINAL OBSTRUCTION 936 0.0248
625 HYPOTENSION 4965 0.0247
626 PHOTOSENSITIVITY REACTION 408 0.0247
627 WRONG TECHNIQUE IN DRUG USAGE PROCESS 897 0.0247
628 PULMONARY EMBOLISM 2346 0.0247
629 FAECES DISCOLOURED 535 0.0247
630 ABASIA 609 0.0246
631 FACIAL PAIN 220 0.0246
632 TINNITUS 1131 0.0246
633 HYPERSOMNIA 705 0.0246
634 HAEMATURIA 842 0.0246
635 PNEUMONIA BACTERIAL 225 0.0245
636 SCAR 419 0.0245
637 SKIN DISORDER 813 0.0244
638 DEVICE RELATED INFECTION 375 0.0243
639 GASTROINTESTINAL PAIN 268 0.0243
640 PRESYNCOPE 592 0.0243
641 ACTIVITIES OF DAILY LIVING IMPAIRED 482 0.0243
642 PULMONARY THROMBOSIS 265 0.0243
643 DRY EYE 1213 0.0243
644 DYSPHONIA 1421 0.0243
645 WHITE BLOOD CELL COUNT DECREASED 2628 0.0242
646 HAEMATOMA 628 0.0242
647 HEAD INJURY 766 0.0242
648 HOSPICE CARE 239 0.0242
649 VENTRICULAR EXTRASYSTOLES 251 0.0241
650 INTESTINAL PERFORATION 271 0.0241
651 INJECTION SITE HAEMORRHAGE 1928 0.0241
652 LEUKOPENIA 1206 0.0241
653 INJECTION SITE PAIN 7395 0.0241
654 MYOCARDIAL ISCHAEMIA 274 0.0241
655 PULMONARY OEDEMA 1077 0.0240
656 VITREOUS FLOATERS 236 0.0240
657 MULTIPLE FRACTURES 394 0.0240
658 HYPONATRAEMIA 1349 0.0239
659 BACTERAEMIA 284 0.0239
660 INJECTION SITE RASH 734 0.0239
661 INJECTION SITE INDURATION 310 0.0239
662 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 404 0.0238
663 HYPERKALAEMIA 834 0.0238
664 BONE MARROW FAILURE 483 0.0237
665 FLATULENCE 1343 0.0237
666 INJECTION SITE URTICARIA 579 0.0236
667 HYPOXIA 830 0.0235
668 APPENDICITIS 220 0.0235
669 EYE DISORDER 772 0.0235
670 EYE INFLAMMATION 224 0.0235
671 GENERALISED OEDEMA 290 0.0234
672 COAGULOPATHY 390 0.0234
673 BLOOD PRESSURE ABNORMAL 465 0.0234
674 SINUS TACHYCARDIA 332 0.0234
675 SNEEZING 524 0.0233
676 MUSCLE ATROPHY 295 0.0233
677 GASTROINTESTINAL HAEMORRHAGE 1946 0.0233
678 INJECTION SITE SWELLING 1784 0.0233
679 INTERSTITIAL LUNG DISEASE 1124 0.0232
680 BLOOD ALKALINE PHOSPHATASE INCREASED 576 0.0232
681 PROCEDURAL PAIN 641 0.0231
682 SWOLLEN TONGUE 721 0.0231
683 LYMPHOMA 356 0.0230
684 GASTRIC DISORDER 788 0.0229
685 BEDRIDDEN 301 0.0229
686 RASH MACULAR 800 0.0229
687 ATAXIA 270 0.0227
688 THERAPY CESSATION 1163 0.0226
689 THROMBOSIS 1821 0.0226
690 DRUG EFFECT INCOMPLETE 822 0.0226
691 TRANSAMINASES INCREASED 503 0.0226
692 DRUG EFFECT DECREASED 1218 0.0226
693 CHEST DISCOMFORT 2313 0.0226
694 QUALITY OF LIFE DECREASED 302 0.0225
695 URINARY RETENTION 751 0.0225
696 CARDIAC FAILURE CONGESTIVE 1807 0.0225
697 OFF LABEL USE 19640 0.0224
698 TACHYCARDIA 1986 0.0223
699 BREAST PAIN 238 0.0223
700 ORTHOSTATIC HYPOTENSION 388 0.0223
701 ANXIETY 6341 0.0223
702 ACUTE MYOCARDIAL INFARCTION 657 0.0223
703 VERTIGO 1357 0.0222
704 HAEMOPTYSIS 621 0.0222
705 PRURITUS GENERALISED 481 0.0222
706 BLOOD TRIGLYCERIDES INCREASED 393 0.0222
707 ABDOMINAL PAIN LOWER 561 0.0222
708 CONSTIPATION 4837 0.0222
709 BONE PAIN 1296 0.0221
710 SWELLING FACE 1440 0.0221
711 NEUROPATHY PERIPHERAL 2100 0.0221
712 MOTOR DYSFUNCTION 224 0.0220
713 HEMIPARESIS 372 0.0219
714 VAGINAL DISCHARGE 222 0.0219
715 PANCREATITIS 1159 0.0219
716 DRUG INEFFECTIVE 28794 0.0218
717 HAEMATEMESIS 553 0.0218
718 BLOOD PRESSURE DECREASED 1449 0.0218
719 DERMATITIS CONTACT 248 0.0217
720 EATING DISORDER 463 0.0217
721 BLOOD BILIRUBIN INCREASED 586 0.0217
722 DEAFNESS 567 0.0217
723 HYPERTENSIVE CRISIS 241 0.0216
724 RENAL FAILURE 2876 0.0216
725 MENTAL STATUS CHANGES 601 0.0216
726 PARAESTHESIA ORAL 312 0.0216
727 INTERNAL HAEMORRHAGE 247 0.0216
728 BURNING SENSATION 1514 0.0216
729 EYE HAEMORRHAGE 287 0.0215
730 SARS-COV-2 TEST POSITIVE 284 0.0215
731 RASH GENERALISED 556 0.0214
732 INFLUENZA LIKE ILLNESS 1766 0.0214
733 ERYTHEMA 4409 0.0214
734 ANOREXIA 276 0.0214
735 DYSPHAGIA 2025 0.0213
736 VISUAL IMPAIRMENT 2642 0.0213
737 PNEUMOTHORAX 337 0.0212
738 LETHARGY 1221 0.0212
739 MUSCLE TIGHTNESS 343 0.0212
740 FLUID OVERLOAD 308 0.0211
741 RENAL PAIN 224 0.0211
742 MELAENA 465 0.0211
743 RETCHING 450 0.0211
744 SURGERY 1235 0.0210
745 RENAL DISORDER 980 0.0210
746 ANGINA PECTORIS 602 0.0210
747 RASH MACULO-PAPULAR 467 0.0210
748 ASCITES 617 0.0210
749 HYPOAESTHESIA ORAL 316 0.0209
750 OSTEONECROSIS OF JAW 518 0.0209
751 PALPITATIONS 2441 0.0208
752 SYNCOPE 2079 0.0208
753 MIDDLE INSOMNIA 387 0.0207
754 DIABETES MELLITUS 1578 0.0207
755 HEAD DISCOMFORT 366 0.0207
756 MYALGIA 3514 0.0206
757 DEVICE FAILURE 313 0.0205
758 RESPIRATORY FAILURE 1493 0.0205
759 FEBRILE NEUTROPENIA 1351 0.0203
760 MULTI-ORGAN FAILURE 352 0.0203
761 HOT FLUSH 1525 0.0202
762 DIPLOPIA 525 0.0202
763 ERUCTATION 391 0.0202
764 FEELING JITTERY 385 0.0202
765 JAUNDICE 543 0.0202
766 APHASIA 609 0.0201
767 HYPERTHYROIDISM 290 0.0200
768 DYSARTHRIA 754 0.0200
769 PELVIC PAIN 363 0.0200
770 SENSORY DISTURBANCE 320 0.0199
771 RASH ERYTHEMATOUS 953 0.0199
772 LOSS OF CONSCIOUSNESS 2529 0.0197
773 FLUSHING 2006 0.0197
774 NEUTROPHIL COUNT DECREASED 804 0.0197
775 TOXIC EPIDERMAL NECROLYSIS 299 0.0197
776 PRODUCT DOSE OMISSION 1285 0.0197
777 FEEDING DISORDER 399 0.0197
778 INTENTIONAL DOSE OMISSION 556 0.0195
779 POLYNEUROPATHY 233 0.0194
780 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1379 0.0194
781 THIRST 346 0.0193
782 LACRIMATION INCREASED 582 0.0192
783 ORAL DISCOMFORT 265 0.0190
784 COLD SWEAT 336 0.0190
785 RESPIRATORY DISTRESS 526 0.0190
786 COVID-19 3329 0.0190
787 DEMENTIA 530 0.0189
788 UNDERDOSE 1384 0.0189
789 SUBDURAL HAEMATOMA 270 0.0188
790 SKIN FISSURES 368 0.0188
791 AGRANULOCYTOSIS 349 0.0188
792 DERMATITIS 393 0.0187
793 CARDIOMYOPATHY 277 0.0187
794 ILEUS 232 0.0186
795 NEUTROPENIA 2537 0.0186
796 GLOMERULAR FILTRATION RATE DECREASED 228 0.0185
797 COORDINATION ABNORMAL 257 0.0184
798 EJECTION FRACTION DECREASED 286 0.0184
799 BLINDNESS UNILATERAL 259 0.0183
800 PRODUCT USE IN UNAPPROVED INDICATION 4548 0.0183
801 HYPERHIDROSIS 2359 0.0183
802 UNEVALUABLE EVENT 1384 0.0183
803 SOMNOLENCE 3683 0.0183
804 DYSGEUSIA 1358 0.0183
805 TREMOR 3033 0.0183
806 AGEUSIA 455 0.0182
807 DRUG DOSE OMISSION 3015 0.0182
808 SKIN REACTION 256 0.0182
809 DISORIENTATION 720 0.0182
810 SPEECH DISORDER 951 0.0181
811 PERITONITIS 374 0.0180
812 EOSINOPHILIA 315 0.0180
813 VAGINAL HAEMORRHAGE 778 0.0179
814 INSURANCE ISSUE 274 0.0179
815 GENERALISED TONIC-CLONIC SEIZURE 295 0.0178
816 FEELING ABNORMAL 4269 0.0178
817 THROAT TIGHTNESS 480 0.0177
818 HEPATOTOXICITY 395 0.0177
819 MENORRHAGIA 348 0.0177
820 DEPRESSED MOOD 931 0.0176
821 RENAL IMPAIRMENT 1479 0.0176
822 SKIN HAEMORRHAGE 260 0.0175
823 PANCREATITIS ACUTE 393 0.0175
824 ENCEPHALOPATHY 429 0.0175
825 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3148 0.0174
826 COLON CANCER 260 0.0174
827 COGNITIVE DISORDER 814 0.0174
828 TREATMENT NONCOMPLIANCE 953 0.0174
829 LYMPHOPENIA 246 0.0174
830 DEVICE MALFUNCTION 1217 0.0173
831 DISTURBANCE IN ATTENTION 934 0.0173
832 LUNG NEOPLASM MALIGNANT 708 0.0172
833 NIGHTMARE 596 0.0172
834 NERVOUSNESS 898 0.0172
835 EYE PAIN 964 0.0171
836 BONE DENSITY DECREASED 535 0.0171
837 APATHY 249 0.0171
838 LIP SWELLING 564 0.0169
839 OSTEONECROSIS 554 0.0169
840 PULMONARY ARTERIAL HYPERTENSION 244 0.0168
841 ARRHYTHMIA 795 0.0168
842 CIRCULATORY COLLAPSE 285 0.0167
843 DIABETES MELLITUS INADEQUATE CONTROL 296 0.0167
844 THERAPEUTIC RESPONSE SHORTENED 552 0.0166
845 PHARYNGEAL OEDEMA 256 0.0166
846 ACUTE RESPIRATORY DISTRESS SYNDROME 294 0.0166
847 PAIN OF SKIN 447 0.0166
848 CARDIOGENIC SHOCK 238 0.0166
849 ILLNESS 1705 0.0165
850 CONVULSION 946 0.0165
851 ECONOMIC PROBLEM 250 0.0165
852 CARDIAC DISORDER 1541 0.0165
853 UNRESPONSIVE TO STIMULI 425 0.0165
854 HALLUCINATION 1237 0.0164
855 DRUG INTERACTION 2603 0.0164
856 GAMMA-GLUTAMYLTRANSFERASE INCREASED 363 0.0164
857 PANIC ATTACK 595 0.0163
858 THERAPEUTIC RESPONSE UNEXPECTED 732 0.0163
859 CYANOSIS 256 0.0163
860 EMOTIONAL DISORDER 501 0.0162
861 SEIZURE 1874 0.0162
862 HAEMORRHAGE 1696 0.0162
863 VISION BLURRED 2226 0.0162
864 HALLUCINATION, VISUAL 341 0.0161
865 CEREBROVASCULAR ACCIDENT 2728 0.0161
866 EYE SWELLING 599 0.0161
867 MOOD SWINGS 512 0.0160
868 MENTAL IMPAIRMENT 389 0.0160
869 ISCHAEMIC STROKE 286 0.0160
870 CRYING 577 0.0159
871 ECZEMA 826 0.0158
872 HYPOACUSIS 678 0.0157
873 ANAPHYLACTIC REACTION 868 0.0157
874 DELUSION 244 0.0157
875 METABOLIC ACIDOSIS 502 0.0157
876 CARDIAC FAILURE 1256 0.0156
877 HYPOGLYCAEMIA 757 0.0156
878 THERAPY INTERRUPTED 1110 0.0155
879 CHOLESTASIS 296 0.0154
880 CARDIO-RESPIRATORY ARREST 643 0.0154
881 OCULAR HYPERAEMIA 723 0.0152
882 INJECTION SITE MASS 562 0.0152
883 SKIN EXFOLIATION 1277 0.0151
884 BRADYCARDIA 799 0.0150
885 HYPERGLYCAEMIA 548 0.0150
886 DYSKINESIA 611 0.0150
887 ACUTE MYELOID LEUKAEMIA 234 0.0150
888 CHOKING 292 0.0150
889 MUSCLE TWITCHING 345 0.0150
890 VENTRICULAR TACHYCARDIA 247 0.0149
891 PROTEINURIA 283 0.0149
892 VISUAL ACUITY REDUCED 494 0.0149
893 INCREASED APPETITE 284 0.0148
894 METASTASES TO BONE 242 0.0147
895 PRODUCT SUBSTITUTION ISSUE 845 0.0147
896 ACNE 1107 0.0146
897 FEAR 390 0.0145
898 RENAL INJURY 429 0.0144
899 MYOCARDIAL INFARCTION 2512 0.0144
900 INCORRECT DOSE ADMINISTERED 3276 0.0143
901 DRUG LEVEL INCREASED 236 0.0142
902 PLASMA CELL MYELOMA 554 0.0142
903 MULTIPLE ORGAN DYSFUNCTION SYNDROME 402 0.0142
904 PRODUCT PRESCRIBING ERROR 338 0.0142
905 DEVICE ISSUE 1263 0.0141
906 CARDIOVASCULAR DISORDER 356 0.0140
907 METASTASES TO LIVER 245 0.0139
908 RESTLESSNESS 509 0.0139
909 ACCIDENTAL OVERDOSE 508 0.0139
910 THINKING ABNORMAL 258 0.0138
911 DRY SKIN 1846 0.0138
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 398 0.0138
913 INTENTIONAL PRODUCT MISUSE 1207 0.0138
914 HOSPITALISATION 2109 0.0137
915 CEREBRAL HAEMORRHAGE 486 0.0136
916 TOOTH LOSS 277 0.0133
917 MOOD ALTERED 358 0.0131
918 CARDIAC ARREST 1083 0.0131
919 CEREBRAL INFARCTION 318 0.0130
920 ABNORMAL DREAMS 359 0.0130
921 PARANOIA 222 0.0129
922 MENTAL DISORDER 559 0.0128
923 ANGER 434 0.0128
924 BLINDNESS 522 0.0128
925 PRODUCT QUALITY ISSUE 1728 0.0127
926 NERVOUS SYSTEM DISORDER 397 0.0127
927 ANHEDONIA 334 0.0127
928 EYE PRURITUS 426 0.0127
929 PRODUCT AVAILABILITY ISSUE 285 0.0125
930 AGITATION 916 0.0125
931 DISEASE PROGRESSION 1469 0.0124
932 NEOPLASM MALIGNANT 827 0.0124
933 SUICIDAL IDEATION 1133 0.0124
934 NEEDLE ISSUE 358 0.0123
935 PRODUCT DOSE OMISSION ISSUE 3605 0.0122
936 IRRITABILITY 730 0.0121
937 STEVENS-JOHNSON SYNDROME 268 0.0120
938 COMA 572 0.0120
939 BLOOD GLUCOSE DECREASED 576 0.0120
940 PSYCHOTIC DISORDER 351 0.0119
941 BLOOD GLUCOSE INCREASED 2199 0.0117
942 PRODUCT DOSE OMISSION IN ERROR 325 0.0115
943 EYE IRRITATION 657 0.0114
944 MULTIPLE SCLEROSIS 542 0.0113
945 ERECTILE DYSFUNCTION 291 0.0113
946 HEPATIC FAILURE 340 0.0113
947 DEVICE DISLOCATION 486 0.0112
948 AGGRESSION 559 0.0112
949 CYTOKINE RELEASE SYNDROME 223 0.0111
950 INCORRECT PRODUCT ADMINISTRATION DURATION 240 0.0111
951 ELECTROCARDIOGRAM QT PROLONGED 397 0.0110
952 SKIN IRRITATION 493 0.0108
953 MALIGNANT NEOPLASM PROGRESSION 1086 0.0106
954 RHABDOMYOLYSIS 439 0.0105
955 ABNORMAL BEHAVIOUR 412 0.0104
956 DRUG ADMINISTRATION ERROR 319 0.0104
957 DISEASE RECURRENCE 484 0.0102
958 MULTIPLE SCLEROSIS RELAPSE 694 0.0101
959 PHARMACEUTICAL PRODUCT COMPLAINT 256 0.0098
960 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 538 0.0098
961 DEPRESSED LEVEL OF CONSCIOUSNESS 383 0.0097
962 SKIN BURNING SENSATION 675 0.0094
963 MENSTRUATION IRREGULAR 248 0.0092
964 BREAST CANCER 861 0.0092
965 ANGIOEDEMA 407 0.0092
966 INCORRECT DRUG ADMINISTRATION DURATION 257 0.0091
967 GLYCOSYLATED HAEMOGLOBIN INCREASED 227 0.0090
968 HEPATIC FUNCTION ABNORMAL 331 0.0089
969 ANAPHYLACTIC SHOCK 228 0.0088
970 SEDATION 227 0.0087
971 NEOPLASM PROGRESSION 301 0.0086
972 DEATH 7277 0.0084
973 OVERDOSE 1816 0.0084
974 RESPIRATORY ARREST 232 0.0084
975 WITHDRAWAL SYNDROME 343 0.0082
976 TOXICITY TO VARIOUS AGENTS 1347 0.0080
977 LACTIC ACIDOSIS 253 0.0078
978 EXPIRED PRODUCT ADMINISTERED 222 0.0067
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1329 0.0066
980 MYELOSUPPRESSION 236 0.0065
981 EMOTIONAL DISTRESS 790 0.0065
982 PROSTATE CANCER 483 0.0060
983 DEVICE LEAKAGE 257 0.0059
984 SUICIDE ATTEMPT 319 0.0053
985 ACCIDENTAL EXPOSURE TO PRODUCT 513 0.0050
986 PRODUCT STORAGE ERROR 363 0.0041
987 NO ADVERSE EVENT 730 0.0040
988 DRUG WITHDRAWAL SYNDROME 328 0.0037
989 DEVICE EXPULSION 220 0.0034
990 DRUG ABUSE 258 0.0031
991 DRUG DEPENDENCE 291 0.0018